IMMUNOTHERAPEUTIC TARGETING OF SLC39A9 IN CDKN2A-LOW MELANOMA

$1,101,574FY2025Defense Health AgencyDOD

The Wistar Institute Of Anatomy And Biology

Investigators

View source on USAspending →